Dow Scientists work on COVID-19 vaccine

Dow University of Health Sciences attained a milestone by preparing intravenous immunoglobulin (IVIG) with plasma obtained from recovered patients of Corona Virus through which affected sufferers can be treated.

As per Dow research team the treatment is safe, low risk and highly effective. Immunoglobulin is prepared after separation of antibodies found in the blood of recovered patient from the corona. The method is a type of passive immunization but uses purified antibodies rather than the whole plasma.

The team first isolated the SARS-COV2 virus for genome sequencing, then discovered human genes resisting the virus, and now has isolated and purified the antibodies composed of immunoglobulin’s fraction of the recovered patients’ plasma.

Trends Stock

Trends Stock provides information about the latest and upcoming trends in the fields of technology, business, education and sports mainly in Pakistan. To keep pace with this fast growing age of development, one can easily build an opinion about the newest trends by scrolling through relevant sections of the website. The first hand reliable data eases the individual to analyze the cutting edge drifts in the related arenas while making any decision.

Previous Post
Next Post